Grace Therapeutics
GRCE
11 hedge funds and large institutions have $204K invested in Grace Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
8% more capital invested
Capital invested by funds: $190K → $204K (+$14.5K)
0.01% less ownership
Funds ownership: 0.15% → 0.15% (-0.01%)
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$7.51K |
| 2 |
Jane Street
New York
|
+$7.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$11.5K |
| 2 |
VF
Virtu Financial
New York
|
-$10K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.72K |
| 4 |
JP Morgan Chase
New York
|
-$1K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$115 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TPCW
1
TD Private Client Wealth
New York
| $126K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $35K | -$11.5K | -3,861 | -26% |
|
3
National Bank of Canada
Montreal,
Quebec, Canada
| $9.66K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $9.63K | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| $7.92K | +$7.51K | +2,515 | New |
|
|
6
Jane Street
New York
| $7.46K | +$7.07K | +2,369 | New |
|
7
Morgan Stanley
New York
| $5.93K | – | – | – |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $94 | -$3 | -1 | -3% |
|
|
IGWM
10
ICA Group Wealth Management
Denver,
Colorado
| $29 | – | – | – |
|
|
TWC
11
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3 | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$10K | -3,709 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$1.72K | -624 | Closed |
|
|
14
JP Morgan Chase
New York
| – | -$1K | -208 | Closed |
|
|
ASN
15
Advisory Services Network
Atlanta,
Georgia
| – | -$115 | -42 | Closed |
|
GRCE Hedge Fund Activity: Q2 2023 in Review
11 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2023, worth a combined $204K — up 7.6% from $190K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GRCE and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $7.51K. The largest seller was Renaissance Technologies, cutting an estimated $11.5K.
- 11 institutional investors held Grace Therapeutics (GRCE) as of Q2 2023, down from 13 in Q1 2023.
- Funds reported $204K of Grace Therapeutics stock for Q2 2023, up 7.6% quarter-over-quarter.
- 2 funds opened new Grace Therapeutics positions in Q2 2023 and 4 closed out, a net change of -2 holders.
- The largest Grace Therapeutics buyer in Q2 2023 was Two Sigma Securities, an estimated $7.51K added.
- The largest Grace Therapeutics seller in Q2 2023 was Renaissance Technologies, an estimated $11.5K sold.
Based on aggregated 13F filings for Q2 2023.